Directorate Change
Optima Health plc announced that Chief Financial Officer Heidi Giles will depart on July 31, 2026, after a significant tenure that included facilitating the company's 2024 IPO. Andrew Bones is slated to become Interim CFO, contingent on the successful completion of the PAM Healthcare acquisition. Giles will remain a director to ensure a smooth transition.
Select text to share a quote on X · sign in to keep highlights & notes in your OPT notes
LONDON, UK, 23 March 2026, Optima Health (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, today announces that Heidi Giles, Chief Financial Officer, will leave the Company on 31 July 2026. Subject to the successful completion of the recently announced acquisition of PAM Healthcare, Optima will appoint Andrew Bones as Interim Chief Financial Officer. Heidi remains a director of the Company during this period, and will continue to fulfil her current role facilitating a smooth transition. Further announcements will be made as appropriate.
Jonathan Thomas, Chief Executive Officer of Optima Health, said: "Heidi has made a significant contribution to the success of Optima Health, bringing professionalism, expertise, and rigour to our financials and through wider support throughout the business. Heidi's committed and diligent work was fundamental to Optima executing the IPO in 2024, and the strong strategic progress made since, and leaves a strong platform for our future success. Heidi has been a great colleague and business partner, and I thank her for her service to Optima Health and wish her nothing but the best in her future."
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.